サイクリンD1欠乏症をノッキンサイクリンEによって救済する
Y Geng1, W Whoriskey, M Y Park
1Dana-Farber Cancer Institute, and Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115, USA.
Cell
|June 25, 1999
まとめ
サイクリンEは,マウスのサイクリンD1を機能的に置き換えて,発達障害を救済することができます. これは,サイクリンEがサイクリンD1の主要な下流標的であり,細胞周期調節に影響を及ぼすことを示唆しています.
科学分野:
- 分子生物学は分子生物学である.
- 細胞サイクル規制について
- 遺伝学 遺伝学とは
背景:
- D型サイクリンとサイクリンEは,哺乳類のG1サイクリンの一種である.
- サイクリンD1 (Ccnd1) は,細胞サイクル進行と発達において重要な役割を果たします.
- 異なるG1サイクリン間の機能的関係を理解することは,細胞サイクル制御を理解するために不可欠です.
研究 の 目的:
- サイクリンEがサイクリンDを機能的に置換できるかどうかを調査する1.
- サイクリンEがサイクリンDのダウンストリームターゲットであるかどうかを判断する1.
- サイクリンD1をサイクリンEに置き換えることでマウスの発達に及ぼす影響を分析する.
主な方法:
- 遺伝子編集を用いた遺伝子組み換えマウス株の生成.
- 固有のサイクリンD1 (Ccnd1) のコード配列の削除.
- Ccnd1をヒトサイクリンE (CCNE) のコード配列に置き換える.
- 様々な組織と細胞におけるCCNE発現パターンの分析.
- Ccnd1-欠乏したマウスのフェノタイプ的救済と正常な発達の回復の評価.
主要な成果:
- 人間のサイクリンE (CCNE) 発現は,マウスサイクリンD1 (Ccnd1) の正常なパターンを成功裏に模倣した.
- サイクリンD1をサイクリンEに置き換えることで,サイクリンD1欠乏症に関連した観察された全ての現象異常が回復しました.
- サイクリンD1機能に依存する組織では正常な発達が回復した.
結論:
- サイクリンEは,哺乳類のサイクリンD1を機能的に置き換えることができる.
- サイクリンEはサイクリンD1の主要な下流標的として作用し,その効果を媒介する.
- この研究は,G1サイクリン冗長性および細胞サイクル制御メカニズムに関する重要な洞察を提供します.
関連する概念動画
Positive Regulator Molecules
To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
Positive Regulator Molecules
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
M-Cdk Drives Transition Into Mitosis
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Anaphase Promoting Complex
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
Inhibition of CDK Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...


